There is a large unmet medical need for patients suffering from functional Gastro-intestinal disorders. Naronapride, a late-development stage, Phase-3 ready, oral gastro-prokinetic drug in the class...
Location: United States, California, Menlo Park
Investors 1
| Date | Name | Website |
| - | Atheneos V... | atheneosve... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 12.04.2022 | Gastrointestinal Biotech Company Renexxion Ireland Announces... | ROSCREA, Ireland, April 12, 2022 /PRNewswire/ -- Renexxion Ireland Ltd., a private biopharmaceutical... | en.prnasia... |